- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
POZIATS Report – Ho Chi Minh City Mental Hospital
On the afternoon of July 16, 2019, at the regular scientific event of Ho Chi Minh City Mental Hospital with 40 attending doctors, Medbolide Joint Stock Company had a report introducing the product POZIATS (Aripirazole 5mg) to the audience. topic "Aripiprazole - New generation antipsychotic drug".
Clinical research results showing the novelty, broad-spectrum effectiveness, safety, low toxicity of Aripiprazole and the distinct advantages of POZIATS were reported by representatives of Medbolide Company. Studies on the effectiveness of Aripiprazole in each indication have been clarified, including: Bipolar disorder, autism, depression, schizophrenia, Tourette syndrome and alcohol/substance-induced psychosis.
At the end of the presentation, Dr. Trung Hoang (Head of Testing Department) shared more in-depth, once again affirming the novelty and specialness of Aripiprazole's "smart" mechanism of action on each receptor at each corresponding dose.
With the mission of improving the health quality of Vietnamese people, Medbolide Company hopes to continue accompanying doctors and patients with products with good treatment effects, providing solutions for diseases. mental illness in particular and other diseases in general.
Readers comments